DG Health Acid Reducer Ranitidine Tablets 150 mg — Class II drug recall D-0526-2020
Ongoing recall by AuroMedics Pharma LLC, reported 2019-12-04, distributed nationwide. CGMP Deviations: N-nitrosodimethylamine (NDMA) has been detected in Ranitidine tablets, capsules and syrups.
| Recall number | D-0526-2020 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | AuroMedics Pharma LLC, East Windsor, NJ, United States |
| Recall initiated | 2019-11-06 |
| Classified | 2019-11-26 |
| Reported by FDA | 2019-12-04 |
| Distributed | Nationwide (US) |
| Quantity | 69,696 bottles |
| Reason classes | chemical contamination, cgmp |
| NDC | 55910-0092-79 |
| Lot numbers | NBSB19001DA3 |
| Expiration dates | 2021-02-20 |
Product
DG Health Acid Reducer Ranitidine Tablets 150 mg, 8-count carton, Distributed by: Dolgencorp LLC 100 Mission Ridge Goodletville TN 37072 NDC 55910-092-79
Reason for recall
CGMP Deviations: N-nitrosodimethylamine (NDMA) has been detected in Ranitidine tablets, capsules and syrups.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0526-2020. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.